-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U25Mrw1iH6JjQHAIjYVlr+kjnM4v2fC1E0E5FP/LLA2HWZyp/VyNhL1VL6gr6tJw kn0lvQPXyRnWG2Ys3ukMUQ== 0000950142-04-004416.txt : 20041221 0000950142-04-004416.hdr.sgml : 20041221 20041221194354 ACCESSION NUMBER: 0000950142-04-004416 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041217 FILED AS OF DATE: 20041221 DATE AS OF CHANGE: 20041221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOENVISION INC CENTRAL INDEX KEY: 0001028205 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113375915 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE STREET 2: 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 212-750-6700 MAIL ADDRESS: STREET 1: 345 PARK AVENUE STREET 2: 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: ASCOT GROUP INC DATE OF NAME CHANGE: 19961205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOROS GEORGE CENTRAL INDEX KEY: 0000900203 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31787 FILM NUMBER: 041218837 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE STREET 2: 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-262--6 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 33RD FLR CITY: NEW YORK STATE: NY ZIP: 10106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOROS FUND MANAGEMENT LLC CENTRAL INDEX KEY: 0001029160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-31787 FILM NUMBER: 041218838 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVENUE 33RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 2128721054 MAIL ADDRESS: STREET 1: C/O AKIN, GUMP, STRAUSS,HAUER,FELD, STREET 2: 399 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 form4-sfmllc121704_bioex.xml FORM 4 X0202 4 2004-12-17 0 0001028205 BIOENVISION INC BIVN 0001029160 SOROS FUND MANAGEMENT LLC 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 0 0 1 1 See Footnotes (3) and (4) 0000900203 SOROS GEORGE 888 SEVENTH AVENUE 33RD FLOOR NEW YORK NY 10106 0 0 1 1 See Footnotes (3) and (4) Common Stock, $0.001 par value ("Common Stock") 2004-12-17 4 S 0 941 8.60 D 746654 I See Footnotes Common Stock 2004-12-17 4 S 0 244 8.60 D 746410 I See Footnotes Common Stock 2004-12-17 4 S 0 941 8.61 D 745469 I See Footnotes Common Stock 2004-12-17 4 S 0 244 8.61 D 745225 I See Footnotes Common Stock 2004-12-17 4 S 0 5177 8.63 D 740048 I See Footnotes Common Stock 2004-12-17 4 S 0 1341 8.63 D 738707 I See Footnotes Common Stock 2004-12-17 4 S 0 471 8.65 D 738236 I See Footnotes Common Stock 2004-12-17 4 S 0 122 8.65 D 738114 I See Footnotes Common Stock 2004-12-17 4 S 0 2622 8.67 D 735492 I See Footnotes Common Stock 2004-12-17 4 S 0 680 8.67 D 734812 I See Footnotes Common Stock 2004-12-17 4 S 0 5514 8.68 D 729298 I See Footnotes Common Stock 2004-12-17 4 S 0 1429 8.68 D 727869 I See Footnotes Common Stock 2004-12-17 4 S 0 4236 8.70 D 723633 I See Footnotes Common Stock 2004-12-17 4 S 0 1098 8.70 D 722535 I See Footnotes Common Stock 2004-12-17 4 S 0 6724 8.71 D 715811 I See Footnotes Common Stock 2004-12-17 4 S 0 1743 8.71 D 714068 I See Footnotes Common Stock 2004-12-17 4 S 0 1076 8.72 D 712992 I See Footnotes Common Stock 2004-12-17 4 S 0 279 8.72 D 712713 I See Footnotes Common Stock 2004-12-17 4 S 0 5446 8.73 D 707267 I See Footnotes Common Stock 2004-12-17 4 S 0 1411 8.73 D 705856 I See Footnotes Common Stock 2004-12-17 4 S 0 269 8.74 D 705587 I See Footnotes Common Stock 2004-12-17 4 S 0 70 8.74 D 705517 I See Footnotes Common Stock 2004-12-17 4 S 0 202 8.80 D 705315 I See Footnotes Common Stock 2004-12-17 4 S 0 52 8.80 D 705263 I See Footnotes These shares sold were held by Quantum Industrial Partners LDC ("QIP"). These shares sold were held by Perseus-Soros Partners, LLC, a Delaware limited liability company ("Perseus-Soros Partners"). The securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP, a Delaware limited partnership ("Perseus-Soros"), Perseus-Soros Partners and QIP. Following the transactions reported herein and in the other Form 4's filed by the reporting persons on December 21,2004, Perseus-Soros owns 375,044 shares, Perseus-Soros Partners owns 57,165 shares and QIP owns 220,563 shares. Soros Fund Management LLC ("SFM LLC") and George Soros ("Mr. Soros") (together, the "Reporting Persons") may be deemed to indirectly beneficially own the shares owned of record by Perseus-Soros, Perseus-Soros Partners and QIP. Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934, as amended (the "Act"), SFM LLC and Mr. Soros are deemed to be beneficial owners of the shares beneficially owned by Perseus-Soros, Perseus-Soros Partners or QIP only to the extent of the greater of his or its respective direct or indirect interest in the profits or capital account of Perseus-Soros, Perseus-Soros Partners or QIP. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that SFM LLC or Mr. Soros is, for purposes of Section 16 of the Act or otherwise, the beneficial owner of any securities owned by Perseus-Soros, Perseus-Soros Partners or QIP in excess of such amount. (5) Mr. Brown is signing in his capacity as Ass't General Counsel of Soros Fund Management LLC. (6) Mr. Brown is signing in his capacity as Attorney-in-Fact for George Soros. /s/ John F. Brown, Soros Fund Management LLC (5) 2004-12-21 /s/ John F. Brown, Attorney-in-Fact for George Soros (6) 2004-12-21 -----END PRIVACY-ENHANCED MESSAGE-----